{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:00:48Z","timestamp":1766516448619,"version":"build-2065373602"},"reference-count":58,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","award":["SUBZ.D150.25.007"],"award-info":[{"award-number":["SUBZ.D150.25.007"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Disorders in glucose metabolism are well-established features of polycystic ovary syndrome (PCOS) and are linked to its clinical severity and phenotypic variability. This study aimed to assess serum concentrations of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and dipeptidyl peptidase-4 (DPP-4) and to examine their relationships with glucose and insulin levels, selected sex hormone concentrations, body weight, and exposure to tobacco smoke. Women with PCOS exhibited significantly elevated levels of fasting glucose, insulin, GIP, and GLP-1 compared to controls. Tobacco smoke exposure in women with PCOS was associated with reduced DPP-4 levels, which were approximately two-fold lower in smokers than in non-smokers. A significant negative correlation between DPP-4 and cotinine levels further supported this relationship. Comorbidities such as overweight\/obesity or insulin resistance (IR) were also linked to elevated incretin hormone levels. However, no significant age-related trends in incretin levels were identified, despite the known association between age and glucose dysregulation. The notable alterations in incretin hormone profiles in PCOS, along with the consistent patterns of GIP or GLP-1 with metabolic and hormonal parameters, suggest that these hormones may play coordinated regulatory roles in the pathophysiology of PCOS.<\/jats:p>","DOI":"10.3390\/ijms26157097","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T11:52:47Z","timestamp":1753271567000},"page":"7097","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of Serum GIP, GLP-1, and DPP-4 with Metabolic and Hormonal Profiles and Tobacco Exposure in Women with Polycystic Ovary Syndrome"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-6878","authenticated-orcid":false,"given":"Anna","family":"Bizo\u0144","sequence":"first","affiliation":[{"name":"Department of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Borkowska","sequence":"additional","affiliation":[{"name":"Students Scientific Society at the Department of Toxicology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0127-7258","authenticated-orcid":false,"given":"Grzegorz","family":"Franik","sequence":"additional","affiliation":[{"name":"Department of Endocrinological Gynecology, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Piwowar","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired Glucose Tolerance, Type 2 Diabetes and Metabolic Syndrome in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2011.11.036","article-title":"Should All Women with PCOS Be Treated for Insulin Resistance?","volume":"97","author":"Marshall","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cen.14181","article-title":"Disorders of the Glucose Metabolism Correlate with the Phenotype and the Severity in Women with Polycystic Ovary Syndrome","volume":"93","author":"Evliyaoglu","year":"2020","journal-title":"Clin. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mce.2006.02.001","article-title":"Insulin Augments GnRH-Stimulated LHbeta Gene Expression by Egr-1","volume":"249","author":"Buggs","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jc.2007-2656","article-title":"Evidence for Insulin Suppression of Baseline Luteinizing Hormone in Women with Polycystic Ovarian Syndrome and Normal Women","volume":"93","author":"Lawson","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ajog.2004.01.054","article-title":"Insulin Enhances the Transcription of Luteinizing Hormone-\u03b2 Gene","volume":"191","author":"Dorn","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cen.12086","article-title":"Sex Hormone Binding Globulin and Insulin Resistance","volume":"78","author":"Wallace","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e240269","DOI":"10.1530\/JOE-24-0269","article-title":"Reappraising the Relationship between Hyperinsulinemia and Insulin Resistance in PCOS","volume":"265","author":"Houston","year":"2025","journal-title":"J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12020-018-1692-3","article-title":"Psychiatric Disorders in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"62","author":"Brutocao","year":"2018","journal-title":"Endocrine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"bqab065","DOI":"10.1210\/endocr\/bqab065","article-title":"The Role of Incretins on Insulin Function and Glucose Homeostasis","volume":"162","author":"Holst","year":"2021","journal-title":"Endocrinology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"170183","DOI":"10.1016\/j.peptides.2019.170183","article-title":"Evaluation of the Incretin Effect in Humans Using GIP and GLP-1 Receptor Antagonists","volume":"125","author":"Gasbjerg","year":"2020","journal-title":"Peptides"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2025.03.003","article-title":"Structural Pharmacology and Mechanisms of GLP-1R Signaling","volume":"46","author":"Zhou","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1210\/endrev\/bnaf006","article-title":"Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease","volume":"46","author":"Wolfe","year":"2025","journal-title":"Endocr. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1507\/endocrj.EJ25-0087","article-title":"Physiology and Clinical Applications of GIP","volume":"72","author":"Yamane","year":"2025","journal-title":"Endocr. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/dc09-2062","article-title":"Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients with Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database","volume":"33","author":"Horton","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_16","first-page":"45","article-title":"DPP-4 Inhibitors and GLP-1RAs: Cardiovascular Safety and Benefits","volume":"9","author":"Razavi","year":"2022","journal-title":"Mil. Med. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31816a4ed4","article-title":"Use of Metformin in Polycystic Ovary Syndrome: A Meta-Analysis","volume":"111","author":"Creanga","year":"2008","journal-title":"Obstet. Gynecol."},{"doi-asserted-by":"crossref","unstructured":"Zhou, L., Qu, H., Yang, L., and Shou, L. (2023). Effects of GLP1RAs on Pregnancy Rate and Menstrual Cyclicity in Women with Polycystic Ovary Syndrome: A Meta-Analysis and Systematic Review. BMC Endocr. Disord., 23.","key":"ref_18","DOI":"10.1186\/s12902-023-01500-5"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2337\/dc17-1818","article-title":"Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared with Nonsmokers","volume":"41","author":"Bagger","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00592-014-0599-6","article-title":"Smoking Is Associated with Impaired Glucose Regulation and a Decrease in Insulin Sensitivity and the Disposition Index in First-Degree Relatives of Type 2 Diabetes Subjects Independently of the Presence of Metabolic Syndrome","volume":"51","author":"Piatti","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/1559827617726516","article-title":"Cigarette Smoking: An Accessory to the Development of Insulin Resistance","volume":"13","author":"Artese","year":"2019","journal-title":"Am. J. Lifestyle Med."},{"doi-asserted-by":"crossref","unstructured":"Mansour, A., Mirahmad, M., Mohajeri-Tehrani, M.R., Jamalizadeh, M., Hosseinimousa, S., Rashidi, F., Asili, P., and Sajjadi-Jazi, S.M. (2023). Risk Factors for Insulin Resistance Related to Polycystic Ovarian Syndrome in Iranian Population. Sci. Rep., 13.","key":"ref_22","DOI":"10.1038\/s41598-023-37513-2"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin Resistance in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Euglycaemic\u2013Hyperinsulinaemic Clamp Studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum. Reprod."},{"doi-asserted-by":"crossref","unstructured":"Gieroba, B., Kryska, A., and Sroka-Bartnicka, A. (2025). Type 2 Diabetes Mellitus-Conventional Therapies and Future Perspectives in Innovative Treatment. Biochem. Biophys. Rep., 42.","key":"ref_24","DOI":"10.1016\/j.bbrep.2025.102037"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/cen.12468","article-title":"Fasting and Post-Prandial Glucagon like Peptide 1 and Oral Contraception in Polycystic Ovary Syndrome","volume":"81","author":"Aydin","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2478\/amb-2024-0071","article-title":"Fasting GLP-1 Levels in Women with PCOS and CAH","volume":"51","author":"Robeva","year":"2024","journal-title":"Acta Medica Bulg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0042-101165","article-title":"Basic and Meal Stimulated Plasma GIP Levels Are Higher in Lean PCOS Women with FAI over 5","volume":"124","author":"Milewicz","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"doi-asserted-by":"crossref","unstructured":"Seon, M.J., Hwang, S.Y., Son, Y., Song, J., and Kim, O.Y. (2021). Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women. Nutrients, 13.","key":"ref_28","DOI":"10.3390\/nu13030865"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"E2539","DOI":"10.1210\/jc.2014-1180","article-title":"Circulating Irisin and Glucose-Dependent Insulinotropic Peptide Are Associated with the Development of Polycystic Ovary Syndrome","volume":"99","author":"Chang","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"170233","DOI":"10.1016\/j.peptides.2019.170233","article-title":"Emerging Role of GIP and Related Gut Hormones in Fertility and PCOS","volume":"125","author":"Moffett","year":"2020","journal-title":"Peptides"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/jwh.2010.2272","article-title":"The Incretin Effect and Secretion in Obese and Lean Women with Polycystic Ovary Syndrome: A Pilot Study","volume":"20","author":"Pontikis","year":"2011","journal-title":"J. Womens Health"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.13129","article-title":"Incretin Hormones: Their Role in Health and Disease","volume":"20","author":"Nauck","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin Levels in Polycystic Ovary Syndrome","volume":"159","author":"Vrbikova","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ypmed.2017.05.025","article-title":"Healthy Lifestyle and Glucagon-like Peptide-1 in Young and Healthy Adults: A Population-Based Study","volume":"101","author":"Krisai","year":"2017","journal-title":"Prev. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.33549\/physiolres.933154","article-title":"No Change in Serum Incretins Levels but Rise of Leptin Levels after Smoking Cessation: A Pilot Study","volume":"65","author":"Pankova","year":"2016","journal-title":"Physiol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/EJE-13-0590","article-title":"Effects of Smoking Cessation on \u03b2-Cell Function, Insulin Sensitivity, Body Weight, and Appetite","volume":"170","author":"Stadler","year":"2014","journal-title":"Eur. J. Endocrinol."},{"doi-asserted-by":"crossref","unstructured":"Driva, S., Korkontzelou, A., Tonstad, S., Tentolouris, N., Litsiou, E., Vasileiou, V., Vassiliou, A.G., Saltagianni, V., and Katsaounou, P. (2024). Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus. Biomedicines, 12.","key":"ref_37","DOI":"10.3390\/biomedicines12081882"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.rbmo.2010.02.021","article-title":"Effect of Cigarette Smoking upon Reproductive Hormones in Women of Reproductive Age: A Retrospective Analysis","volume":"20","author":"Waylen","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCRESAHA.118.312806","article-title":"Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk","volume":"123","author":"Chia","year":"2018","journal-title":"Circ. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2013.02.010","article-title":"Diabetes and Altered Glucose Metabolism with Aging","volume":"42","author":"Kalyani","year":"2013","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E1746","DOI":"10.1152\/ajpendo.00460.2007","article-title":"GIP Receptor Antagonism Reverses Obesity, Insulin Resistance, and Associated Metabolic Disturbances Induced in Mice by Prolonged Consumption of High-Fat Diet","volume":"293","author":"McClean","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/humupd\/dml024","article-title":"Obesity and the Role of Gut and Adipose Hormones in Female Reproduction","volume":"12","author":"Gosman","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2017.11.004","article-title":"Incretins Modulate Progesterone Biosynthesis by Regulating Bone Morphogenetic Protein Activity in Rat Granulosa Cells","volume":"178","author":"Nishiyama","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 Receptor Agonists versus Metformin in PCOS: A Systematic Review and Meta-Analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1570161114666161221115324","article-title":"Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome","volume":"15","author":"Tzotzas","year":"2017","journal-title":"Curr. Vasc. Pharmacol."},{"doi-asserted-by":"crossref","unstructured":"Farkas, I., Vastagh, C., Farkas, E., B\u00e1lint, F., Skrapits, K., Hrabovszky, E., Fekete, C., and Liposits, Z. (2016). Glucagon-Like Peptide-1 Excites Firing and Increases GABAergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (GnRH) Neurons of the Male Mice via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways. Front. Cell. Neurosci., 10.","key":"ref_46","DOI":"10.3389\/fncel.2016.00214"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s43032-024-01503-0","article-title":"Liraglutide Improves PCOS Symptoms in Rats by Targeting FDX1","volume":"31","author":"Ji","year":"2024","journal-title":"Reprod. Sci. Thousand Oaks Calif"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/EP-2017-0027","article-title":"DPP4 inhibitor sitagliptin as a potential treatment option in metformin-intolerant obese women with polycystic ovary syndrome: A pilot randomized study","volume":"24","author":"Ferjan","year":"2018","journal-title":"Endocr. Pract."},{"doi-asserted-by":"crossref","unstructured":"Bo, Y., Zhao, J., Liu, C., and Yu, T. (2025). Comparative Efficacy of Pharmacological Interventions on Metabolic and Hormonal Outcomes in Polycystic Ovary Syndrome: A Network Meta-Analysis of Randomized Controlled Trials. BMC Womens Health, 25.","key":"ref_49","DOI":"10.1186\/s12905-025-03594-6"},{"doi-asserted-by":"crossref","unstructured":"Liu, Q.K. (2024). Mechanisms of Action and Therapeutic Applications of GLP-1 and Dual GIP\/GLP-1 Receptor Agonists. Front. Endocrinol., 15.","key":"ref_50","DOI":"10.3389\/fendo.2024.1431292"},{"doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2004). Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS). Hum. Reprod., 19, 41\u201347.","key":"ref_51","DOI":"10.1093\/humrep\/deh098"},{"doi-asserted-by":"crossref","unstructured":"Niepsuj, J., Piwowar, A., Franik, G., and Bizo\u0144, A. (2024). The Concentration of Follistatin and Activin A in Serum and Selected Biochemical Parameters in Women with Polycystic Ovary Syndrome: Stratification by Tobacco Smoke Exposure, Insulin Resistance, and Overweight\/Obesity. J. Clin. Med., 13.","key":"ref_52","DOI":"10.3390\/jcm13175316"},{"key":"ref_53","first-page":"e425","article-title":"Accuracy of Cotinine Serum Test to Detect the Smoking Habit and Its Association with Periodontal Disease in a Multicenter Study","volume":"22","author":"Duque","year":"2017","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"doi-asserted-by":"crossref","unstructured":"Biernacka-Bartnik, A., Koce\u0142ak, P., Owczarek, A.J., Chor\u0119za, P.S., Markuszewski, L., Madej, P., Puzianowska-Ku\u017anicka, M., Chudek, J., and Olszanecka-Glinianowicz, M. (2023). The Cut-off Value for HOMA-IR Discriminating the Insulin Resistance Based on the SHBG Level in Women with Polycystic Ovary Syndrome. Front. Med., 10.","key":"ref_54","DOI":"10.3389\/fmed.2023.1100547"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.17511\/ijmrr.2019.i05.04","article-title":"Comparison of Insulin Resistance Scoring System with Indirect Methods of Estimating Insulin Resistance in Indian Type 2 Diabetes Subjects","volume":"7","author":"Kumar","year":"2019","journal-title":"Int. J. Med. Res. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3945\/ajcn.2008.26847","article-title":"Comparisons of Percentage Body Fat, Body Mass Index, Waist Circumference, and Waist-Stature Ratio in Adults","volume":"89","author":"Flegal","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_57","first-page":"4755","article-title":"The Effect of Abdominal Obesity in Patients with Polycystic Ovary Syndrome on Metabolic Parameters","volume":"21","author":"Franik","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"doi-asserted-by":"crossref","unstructured":"Ashwell, M., and Gibson, S. (2014). A Proposal for a Primary Screening Tool: \u201cKeep Your Waist Circumference to Less than Half Your Height. \u201d BMC Med., 12.","key":"ref_58","DOI":"10.1186\/s12916-014-0207-1"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7097\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:37Z","timestamp":1760033677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":58,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157097"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157097","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}